Star Cement Ltd Leadership Reorganization Approved

Star Cement Limited has successfully completed its leadership transition plan, with shareholders overwhelmingly approving key management role changes through postal ballot voting. The resolutions pave the way for a strategic reshuffling at the top.

What just happened

Shareholders approved the appointment of Mr. Tushar Bhajanka as Managing Director & Chief Executive Officer (CEO) for a three-year term from May 22, 2026, to May 21, 2029. Additionally, Mr. Prem Kumar Bhajanka's designation will change to Vice Chairman & Managing Director, effective May 22, 2026.

Why this matters

This formalization of leadership roles provides clear visibility on the company's executive structure for the next three years, ensuring management continuity and a defined succession plan. The strong shareholder approval reflects confidence in the proposed leadership.

Reader Takeaway: Management continuity secured with strong shareholder backing; clear leadership structure for next three years.

The backstory

Star Cement, a prominent player in the cement industry, has undertaken this restructuring to ensure a smooth and strategic handover of key leadership responsibilities. The postal ballot and remote e-voting process were conducted to maintain transparency and adherence to regulatory norms.

What changes now

The approved changes will officially take effect from May 22, 2026. Mr. Tushar Bhajanka will lead as MD & CEO, while Mr. Prem Kumar Bhajanka will assume the role of Vice Chairman & Managing Director, guiding the company's strategic direction.

Voting Results

All proposed resolutions received significant shareholder support. The resolution for Mr. Tushar Bhajanka's remuneration for April-May 2026 passed with 98.65% in favour. His appointment as MD & CEO secured 99.06% approval, and the designation change for Mr. Prem Kumar Bhajanka to Vice Chairman & MD was approved by 99.90% of the votes.

Context Metrics

• MD & CEO Term: 3 years (May 22, 2026 - May 21, 2029)
• Approval for MD & CEO Appointment: 99.06%
• Approval for Vice Chairman & MD Designation Change: 99.90%